FDA authorizes N95 decontamination system’s emergency use
The Food and Drug Administration May 27 authorized the emergency use of the Stryker Sustainability Solutions VHP N95 Respirator Decontamination System during the COVID-19 pandemic.
The device decontaminates compatible N95 respirators for multiple-user reuse to prevent exposure to pathogenic biological airborne particulates when there are insufficient supplies of face-filtering respirators. Hospitals should note that N95 respirators containing cellulose-based materials are incompatible with the SSS VHP N95 RDS and respirators are limited to a maximum of three decontaminations via the device.
Related News Articles
Headline
The Department of Health and Human Services June 30 announced it will terminate emergency use authorization declarations for certain drugs and medical devices…
Headline
Centers for Medicare & Medicaid Services Administrator Mehmet Oz, M.D., and CMS Deputy Administrator and Director of Medicaid and CHIP Dan Brillman sat…
Headline
Flu and COVID-19 vaccination rates among all health care workers for the 2024-25 respiratory virus season was 76.3% and 40.2%, respectively, according to a…
Headline
A study published March 18 by Science Advances estimated that more than 155,000 U.S. COVID-19 deaths were uncounted during the COVID-19 pandemic. Researchers…
Headline
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including certain wearable devices) and the…